KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $558,141 | -38.3% | 40,154 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $904,450 | -32.7% | 39,341 | -13.3% | 0.00% | -50.0% |
| Q1 2023 | $1,344,817 | +21.4% | 45,387 | +2.3% | 0.00% | 0.0% |
| Q4 2022 | $1,107,750 | +16.0% | 44,381 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $955,000 | +9.0% | 43,862 | -1.4% | 0.00% | +100.0% |
| Q2 2022 | $876,000 | -46.7% | 44,491 | +14.7% | 0.00% | -50.0% |
| Q1 2022 | $1,642,000 | -38.9% | 38,801 | -8.4% | 0.00% | -33.3% |
| Q4 2021 | $2,689,000 | +11.8% | 42,354 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $2,406,000 | +24.5% | 40,964 | +2.8% | 0.00% | +50.0% |
| Q2 2021 | $1,933,000 | +227.1% | 39,855 | +162.1% | 0.00% | +100.0% |
| Q1 2021 | $591,000 | -37.5% | 15,204 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $946,000 | – | 15,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |